Overexpression or knockdown of the P2X7 receptor regulates the progression of non-small cell lung cancer, involving GSK-3β and JNK signaling pathways
- 22 February 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 995, 177421
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 33 references indexed in Scilit:
- TMPOP2 Inhibition Suppresses Pancreatic Cancer Cell Migration and Development by Repressing The JNK/STAT3 PathwayAdvanced Biology, 2023
- P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathwaysPurinergic Signalling, 2023
- A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptorBiochemical and Biophysical Research Communications, 2021
- Human P2X7 receptors – Properties of single ATP-gated ion channelsBiochemical Pharmacology, 2021
- GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2020
- The role of P2X7 receptor in prognosis and metastasis of colorectal cancerAdvances in Medical Sciences, 2019
- Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signalingInternational Journal of Cancer, 2019
- Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells2019
- ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathwayBiomedicine & Pharmacotherapy, 2018
- Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resectionTumor Biology, 2015